Dare Bioscience Inc. (NASDAQ:DARE) went down by -1.85% from its latest closing price compared to the recent 1-year high of $3.85. The company’s stock price has collected 0.63% of gains in the last five trading sessions. Press Release reported on 10/06/21 that Daré Bioscience to Participate in Panel Discussion at DTC Perspectives’ Xpectives.Health Summit, October 12-14, 2021
Is It Worth Investing in Dare Bioscience Inc. (NASDAQ :DARE) Right Now?
Plus, the 36-month beta value for DARE is at 1.62. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Dare Bioscience Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $5.50. DARE currently public float of 47.69M and currently shorts hold a 6.68% ratio of that float. Today, the average trading volume of DARE was 4.04M shares.
DARE’s Market Performance
DARE stocks went up by 0.63% for the week, with a monthly drop of -5.36% and a quarterly performance of 3.92%, while its annual performance rate touched 47.22%. The volatility ratio for the week stands at 4.55% while the volatility levels for the past 30 days are set at 4.54% for Dare Bioscience Inc.. The simple moving average for the period of the last 20 days is -4.79% for DARE stocks with a simple moving average of -5.55% for the last 200 days.
DARE Trading at -4.01% from the 50-Day Moving Average
After a stumble in the market that brought DARE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.70% of loss for the given period.
Volatility was left at 4.54%, however, over the last 30 days, the volatility rate increased by 4.55%, as shares sank -3.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -0.62% lower at present.
During the last 5 trading sessions, DARE rose by +0.63%, which changed the moving average for the period of 200-days by +12.77% in comparison to the 20-day moving average, which settled at $1.6670. In addition, Dare Bioscience Inc. saw 18.66% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for DARE
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.91.